Bioactivity:

Ixazomib citrate is a prodrug of Ixazomib (MMLN-2238).�MLN9708 is an orally bioavailable second generation proteasome inhibitor (IC50 of 3.4 nM ) with potential antineoplastic activity.

CAS nr:

1239908-20-3

Purity:

98%

Molecular Weight:

517,12

SMILES:

CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B1OC(=O)C(CC(O)=O)(CC(O)=O)O1

Formula:

C20H23BCl2N2O9

Pathway:

Proteases/Proteasome,Ubiquitination,Autophagy

Target:

Proteasome,Proteasome,Autophagy